DLK1 and lung carcinoma: miR-493-3p was transcribed from the DLK1-DIO3 genomic region, which has been reported to act as a tumor suppressor in several cancers (lung cancer, lung cancer, bladder cancer and head and neck cancer) by targeting different oncogenes [24-27].